ARTICLE SUMMARY:
Veteran medtech investors report on the current state of early-stage medtech investments and why they remain committed to advancing innovation even in a relatively hostile market.
Raising money for a start-up has become especially difficult over the past five years, but at least some venture investors remain committed to medtech innovation and are optimistic about its future.
